Form 4/A for CRMD CorMedix Inc.
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0000899140-24-001360 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-12-18 | 2024-12-12 | CRMD | Zelnick Kaufman Beth | CLO | F - Tax | $8.77 | -6,044 | 44.0K | -12% | -$53.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-12 | F | D | 6,044 | $8.77 | 43,956 | D | — | — | (F1) The reporting person has filed this amendment to restate the transaction reported in the Form 4 filed December 16, 2024 in order to correct the amount of Common Stock beneficially owned by the reporting person following the transaction and to remove a duplicative reference to the Restricted Stock Units reported in Table II. As reported in this amendment, the reporting person directly beneficially owns 43,956 shares of Common Stock following the reported transaction. |